121 related articles for article (PubMed ID: 166514)
41. Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency.
Simmonds HA; Webster DR; Perrett D; Reiter S; Levinsky RJ
Biosci Rep; 1982 May; 2(5):303-14. PubMed ID: 6980023
[TBL] [Abstract][Full Text] [Related]
42. Some characteristics in the pathway of RNA synthesis in hepatoma cells.
Matsudaira H; Nakamura C; Hishizawa T
Gan; 1968 Feb; 59(1):61-71. PubMed ID: 4298976
[No Abstract] [Full Text] [Related]
43. Enhancement of the biological activity of cordycepin (3'-deoxyadenosine) by the adenosine deaminase inhibitor 2'-deoxycoformycin.
Johns DG; Adamson RH
Biochem Pharmacol; 1976 Jun; 25(12):1441-4. PubMed ID: 1084747
[No Abstract] [Full Text] [Related]
44. Human melanoma cells sensitive to deoxyadenosine and deoxyinosine.
Parsons PG; Hayward IP
Biochem Pharmacol; 1986 Feb; 35(4):655-60. PubMed ID: 3004507
[TBL] [Abstract][Full Text] [Related]
45. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of adenosine deaminase deficiency.
Albert D; Bluestein HG; Thompson L; Seegmiller JE
Cell Immunol; 1984 Jul; 86(2):510-7. PubMed ID: 6610485
[TBL] [Abstract][Full Text] [Related]
46. Altered deoxynucleoside triphosphate levels paralleling deoxyadenosine toxicity in adenosine deaminase inhibited human lymphocytes.
Bluestein HG; Thompson LF; Albert DA; Seegmiller JE
Adv Exp Med Biol; 1980; 122A():427-31. PubMed ID: 6968502
[No Abstract] [Full Text] [Related]
47. Deoxynucleoside overproduction in deoxyadenosine-resistant, adenosine deaminase-deficient human histiocytic lymphoma cells.
Kubota M; Carrera CJ; Wasson DB; Carson DA
Biochim Biophys Acta; 1984 May; 804(1):37-43. PubMed ID: 6372866
[TBL] [Abstract][Full Text] [Related]
48. Adenosine deaminase impairment and ribonucleotide reductase activity and levels in HeLa cells.
Lin AL; Elford HL
J Biol Chem; 1980 Sep; 255(18):8523-8. PubMed ID: 6997299
[TBL] [Abstract][Full Text] [Related]
49. Potentiation of 1-beta-D-arabinofuranosylcytosine in hepatoma cells by 2'-deoxyadenosine or 2'-deoxyguanosine.
Harkrader RJ; Boritzki TJ; Jackson RC
Biochem Pharmacol; 1981 May; 30(10):1099-104. PubMed ID: 6973342
[No Abstract] [Full Text] [Related]
50. Interaction of N-methyl-N'-nitro-N-nitrosoguanidine with ascites hepatoma cells in vitro.
Nagao M; Yokoshima T; Hosoi H; Sugimura T
Biochim Biophys Acta; 1969 Nov; 192(2):191-9. PubMed ID: 4313072
[No Abstract] [Full Text] [Related]
51. Enhanced antibody response in the presence of partial adenosine deaminase inhibition.
Hoffman EA; Kopp WC; Moat AG
Proc Soc Exp Biol Med; 1990 May; 194(1):36-42. PubMed ID: 2139230
[TBL] [Abstract][Full Text] [Related]
52. Factors influencing the inhibition of repair of irradiation-induced DNA damage by 2'-deoxycoformycin and deoxyadenosine.
Begleiter A; Verburg L; Israels LG; Johnston JB
Cancer Chemother Pharmacol; 1992; 30(1):65-9. PubMed ID: 1586982
[TBL] [Abstract][Full Text] [Related]
53. Effects of 8-azaadenosine and formycin on cell lethality and the synthesis and methylation of nucleic acids in human colon carcinoma cells in culture.
Glazer RI; Lloyd LS
Biochem Pharmacol; 1982 Oct; 31(20):3207-14. PubMed ID: 7150349
[TBL] [Abstract][Full Text] [Related]
54. Studies on the mechanism of cytotoxicity of 3'-deoxyadenosine N1-oxide in different strains of Ehrlich ascites tumor cells.
Svendsen KR; Overgaard-Hansen K; Frederiksen S; Loft H; Engelholm SA
Cancer Chemother Pharmacol; 1987; 19(2):118-22. PubMed ID: 3494546
[TBL] [Abstract][Full Text] [Related]
55. Studies on the energy metabolism of opossum Didelphis virginiana erythrocytes--IV. Red cells have low adenosine deaminase activity and high levels of deoxyadenosine nucleotides.
Bethlenfalvay NC; Chadwick E; Lima JE
Life Sci; 1989; 44(14):963-70. PubMed ID: 2784528
[TBL] [Abstract][Full Text] [Related]
56. Potentiation of cytotoxicity and antitumor activity of adenosine analogs by the adenosine deaminase inhibitor adecypenol.
Tanaka H; Kawakami T; Yang ZB; Komiyama K; Omura S
J Antibiot (Tokyo); 1989 Nov; 42(11):1722-4. PubMed ID: 2584153
[No Abstract] [Full Text] [Related]
57. Isolation and characterization of S49 mouse lymphoma cell mutants deficient in adenosine deaminase.
Chan TS; Huang C; Sato T
Somat Cell Mol Genet; 1989 Sep; 15(5):411-20. PubMed ID: 2789437
[TBL] [Abstract][Full Text] [Related]
58. Further studies on the effect of deoxyadenosine on the accumulation of deoxyadenosine triphosphate and inhibition of deoxyribonucleic acid synthesis in Ehrlich ascites tumor cells in vitro.
KLENOW H
Biochim Biophys Acta; 1962 Dec; 61():885-96. PubMed ID: 14033467
[No Abstract] [Full Text] [Related]
59. The nature of inhibitors of DNA synthesis in rat-liver hepatoma cells.
Sasada M; Terayama H
Biochim Biophys Acta; 1969 Sep; 190(1):73-87. PubMed ID: 4309828
[No Abstract] [Full Text] [Related]
60. Deoxyadenosine toxicity in an adenosine deaminase-inhibited human CCRF-CEM T-lymphoblastoid cell line causes cell swelling.
Bagnara AS; McDonald LE; Slade HM
Biochim Biophys Acta; 1992 Dec; 1180(2):163-72. PubMed ID: 1463767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
